Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C

Liver

Volumn 16, Issue 6, 1996, Pages 390-399

  Fukuda, Ryo ^a   Ishimura, Norihisa ^a   Ishihara, Shunji ^a   Chowdhury, Aktaruzzaman ^a   Moriyama, Nobuyuki ^a   Nogami, Chie ^a   Miyake, Tatsuya ^a   Niigaki, Misa ^a   Tokuda, Alejandro ^a   Satoh, Shuichi ^a   Sakai, Shino ^a   Akagi, Shuji ^a   Watanabe, Makoto ^a   Fukumoto, Shiro ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Cytokine; Interferon

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; LIVER; LIVER BIOPSY; MALE; MESSENGER RNA SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 12644302184     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00768.x     Document Type: Article

References (38)

1. MONDELLI M, ALBERTI A, TREMOLAND F, WILLIAMS R, EDDLESTONE A L W F, REALDI G. In vitro cell-mediated cytotoxity for autologous liver cells in chronic non-A. non-B hepatitis. Clin Exp Immunol 1986: 63: 147-155.
2. DIENS H P, HUTTEROTH T, HESSE G, MEUER S C. Immunoelectron microscopic observation on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology 1987: 7: 1317-1325.
3. MARION P, VIELRING J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH. Immunology and the liver. Hepatology 1991: 13: 977-994.
4. FUKUDA R, SATOH S, NGUYEN T X, et al. Expression of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B. J Gastroenterol 1995: 31: 41-47.
5. FUKUDA R, ISHIMURA N, NGUYEN T X, et al. Detection of interleukin-2, 4 and interferon gamma mRNA using liver biopsy specimens in different phases of acute exacerbation of chronic hepatitis B Clin Exp Immunol 1995: 100: 446-415.
6. MAGRIN S, GRAXI A, FABIANO C, et al. Serum hepatitis C virus (HCV)-RNA and response to alpha interferon in anti-HCV positive chronic hepatitis. J Med Viral 1992: 38: 200-206.
7. KANAZAWA Y, HAYASHI N, MITA E, et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994: 20: 1121-1130.
8. YOSHIDA K, KAKUMU S, WAKITA T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha: relationship to genotype of hepatitis C virus. Hepatology 1992: 16: 293-299.
9. WEILAND O, SCHVARZ R, WELJSTAL R, NORKRAN G, FRYDEN. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alpha-2b: Swedish experience. J Hepatol 1990: 11(suppl 19): S57-S62.
10. 2b for 60 weeks. Hepatology 1994: 19: 280-285.
11. NANJI A A, ZHAU S, SADRADEN S M H. WAXMAN D J, Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994: 19: 1483-1487.
12. CASTILLA A, PRIETO J, FAUSTO N, et al. Transforming growth factor-beta 1 and alpha in chronic liver disease: effect of interferon alpha therapy. N Engl J Med 1991: 324: 933-940.
13. ANNONI G, WEINER F, ZERM M, et al. Increased transforming growth factor-beta 1 gene expression in human liver diseases. J Hepatol 1992: 14: 259-264.
14. BAAN C C, VAN EMMERIK N E M, BALK A H M M, et al. Cytokine mRNA expression in endocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994: 197: 293-298
15. MARTINEZ O M, KERNS SM, STERNECK M. et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992: 53: 449-456.
16. OKAMOTO H, SUGLYAMA Y, OKADA S, et al. Typing of hepatitis C virus by polymerase chain reaction with type specific primers; application to clinical surveys and tracing infectious sources. J Gen Virol 1992: 73: 673-679.
17. SIMONNDS P, HOLMES E C, CHA T A. et al. Classification of hepatitis C virus into six major genotypes and a series of subtype by phylogenetic analysis of the NS-5 region. J Gen Virol 1993: 74: 2391-2399.
18. HAGIWARA H, HAYASHI N, MITA E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993: 104: 877-883.
19. KNODELL R G, ISAK K G, BLACK W C. et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981: 1: 431-435.
20. MOSMAN T R, COFFMAN R L. Heterogeneity of cytokine secretion pattern and functions of helper T cells. Adv Immunol 1989: 46: 111-147.
21. KOZIEL M J, DUDDLEY D, WONG J T, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in person with chronic hepatitis. J Immunol 1992: 149: 3339-3344.
22. KITA H, MORIYAMA T, KANEKO T, et al. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 1993: 18: 1039-1044.
23. LÖRH H F, SCHLAAK J F GERKEN G, FLEISHER B, DIENS H P, MEYER ZUM BÜSCHENFELDE K H. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994: 14: 161-166.
24. SHLAAK J F, LÖHR H, GALLATI H, MEYER ZUM BÜSCHEN-FELDE K H, FLEISCHER B. Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 1993: 94: 168-173.
25. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994: 152: 3074-3078.
26. DEL PRETE G F, DE CARLI M, RICCI M, ROMAGNANI S. Helper activity for immunoglobulin synthesis of T helper type 1(Th1) and Th2 human T cell clones: the Th1 clones is limited by their cytolytic capacity. J Exp Med 1991: 174: 809-813.
27. LARSEN C G, ANDERSON A O, APELLA E, OPPENHEIM J J, MATSUSHIMA K. The neutrophil activating protein 1(NAP-1) is also chemotactic for lymphocytes. Science 1989: 243: 1464-1468.
28. FIORENTINO D, BOND M W, MOSMANN T R. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989: 170:2081-2095
29. SARACCO G, ROSINA F, ABART M L, et al. Long-term follow up of patients with chronic hepatitis C treated with different dose of interferon alpha-2b. Hepatology 1993: 18: 1300-1305.
30. SHINDO M, DI BISCEGLI A M, CHEUNG L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Int Med 1991: 115: 700-704.
31. LAU J Y N, MIZOKAMI M, OHNO T, DIAMOND D A, KNIFFEN J, DAVIS G L. Discrepancy between biochemical and virological response to interferon-alpha in chronic hepatitis C. Lancet 1993: 342: 1208-1209.
32. AIYAMA T, YOSHIOKA K, HIGASHI YIET, et al. Changes in serum hepatitis C virus RNA titer and response to Interferon therapy. Hepatology 1993: 8: 88-92.
33. GARCIA BUEY L, BORQUE M J. et al. Long-term follow-up in chronic hepatitis C patients with complete response to one year interferon therapy. Hepatology 1993: 18: 231-236.
34. MCGUINNESS P H. BISHOP G A. PAINTER D M, CHAN R. MACAUGAN G W. Intrahepatic hepatitis C virus RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996: 23: 676-687.
35. REICHARD O, GLAUMANN H. NORKRANS G, et al. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alpha-2b treatment. Hepatology 1995: 21: 918-922.
36. ITO N, KAWATA S. TAMURA S. et al. Induction of interleukin-6 by interferon alpha and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C. Hepatology 1996: 23: 669-675.
37. TSUBOTA A. CHAYAMA K, IKEDA K, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994: 19: 1088-1094.
38. ISHIMURA N, FUKUDA R, FUKUMOTO S. Relationship between the expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus associated chronic liver diseases. J Gastroenterol Hepatol 1996: 11: 712-717.